BLCM — Bellicum Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $0.95m
- -$4.96m
- $1.50m
Brief: Bellicum Pharma Announces Rivo-Cel Achieves Primary Endpoint In Pediatric Registrational Trial
Brief: Bellicum Pharmaceuticals Provides Interim Data For BPX-601 In Patients With Metastatic Pancreatic Cancer
Brief: Bellicum Pharmaceuticals To Present Updated Results For BPX-601 At 2019 ASCO Annual Meeting
Brief: Bellicum Pharmaceuticals Reports First Quarter 2019 Financial Results And Provides Operational Update
Brief: Bellicum Pharma Says On April 4, Entered Into A Supply Agreement With Miltenyi Biotec GMBH
Brief: Bellicum Pharmaceuticals Appoints Judith Klimovsky To Board
Brief: Bellicum Reports Safety Results For Pancreatic Cancer Drug
Brief: Bellicum Pharmaceuticals Appoints Atabak Mokari As CFO
U.S. RESEARCH ROUNDUP- Apple, Chico's Fas, Veeva Systems
Advisory: Alert on Bellicum Pharmaceuticals' quarterly revenue withdrawn
Brief: Bellicum Pharma Qtrly Loss Per Share $0.55
Brief: Bellicum Pharmaceuticals Says Co Entered Into An Open Market Sale Agreement With Jefferies LLC
Brief: Bellicum Pharma Files For Mixed Shelf Of Upto $150 Million
Brief: Bellicum Pharmaceuticals Q2 Net Loss Per Share Attributable $0.60
Brief: Bellicum Pharmaceuticals Says On July 13, Co, CFO, Alan Musso Entered Separation Agreement After Which Musso Resigned Effective Aug 31
Brief: Bellicum Pharmaceuticals Announces Departure Of CFO
Brief: Bellicum Pharmaceuticals Reports Q1 Loss Per Share Of $0.68
Brief: Bellicum Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-Netflix, Newell, Comerica, Twitter, UnitedHealth